Fox Chase Cancer Center Welcomes Stephanie Greco

August 21, 2019

Dr. Greco will join the Department of Surgical Oncology on September 3, focusing on melanoma, sarcoma, and GI.Dr. Greco will join the Department of Surgical Oncology on September 3, focusing on melanoma, sarcoma, and GI.PHILADELPHIA (August 21, 2019) – Fox Chase Cancer Center announces the hiring of Stephanie Greco, MD, who will join the Department of Surgical Oncology as an assistant professor on the academic clinician track. She will focus on melanoma, sarcoma, and GI.

Greco received her medical degree from Rutgers Robert Wood Johnson Medical School. She completed her general surgery residency at New York University School of Medicine, where she was also a postdoctoral research fellow studying tumor immunology. She then completed her fellowship in complex general surgical oncology at the Rutgers Cancer Institute of New Jersey. She is board certified in general surgery.

Greco has received several awards including the NYU Resident Research Award. She is a member of the Society of Surgical Oncology, the American College of Surgeons, and the Association for Academic Surgery.

She has been published in multiple peer-reviewed journals and has presented at several national medical meetings. Greco will begin her work at Fox Chase on September 3, 2019.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.


For more information, call 888-369-2427

Connect with Fox Chase